News

News2018-07-02T16:18:46+00:00

[News Release] Morehouse School of Medicine Awarded $200,000 to Train Minority Physicians for Recruiting Minorities in Clinical Trials

Funded by Clinical Research Pathways, the New Program Intends to Fill a Gap in the Percentage of Minorities Who Participate in Clinical Trials ATLANTA, September 20, 2018 — Morehouse School of Medicine (MSM) will launch a program specifically designed to increase the number of African-American, Latino and other minority patients in clinical trials, in an effort that could eventually lead to the development of medical treatments better tailored for those populations. Under the three-year program, minority physicians will be recruited to [...]

September 20, 2018|Categories: News|

Seeking Physician Input on Using Expanded Access To Experimental Drugs for Their Patients

Clinical Research Pathways Needs Assessment Survey Aims to Assist Physicians ATLANTA, Ga., June 26, 2018— Clinical Research Pathways has launched an effort to learn what information and other resources physicians need to seek access to experimental drugs for desperately ill or terminal patients, using the expanded access program. Under the U.S. Food and Drug Administration's expanded access process, physicians can work with pharmaceutical companies, FDA and institutional review boards to apply for experimental drugs or devices when all treatment options [...]

June 26, 2018|Categories: News|

Clinical Research Pathways Names Two New Directors

ATLANTA, Ga., June 5, 2018 — Clinical Research Pathways has appointed two new members to its board of directors: Anne B. Cropp of Early Access Care and Andrew McFadyen of The Isaac Foundation and Equal Access for Rare Disorders. The former WCG Foundation, Clinical Research Pathways is a public charity that works to improve health and well-being for all by creating pathways to new medicines. The organization seeks to increase diversity in research, enhance access to new medicines and help [...]

June 5, 2018|Categories: News|

WCG Foundation Is Now Clinical Research Pathways

N E W S   R E L E A S E FOR IMMEDIATE RELEASE                  May 23, 2018 WCG Foundation Is Now Clinical Research Pathways New name reflects focus on expanded access and inclusion in research. ATLANTA, Ga., May 23, 2018—WCG Foundation is now Clinical Research Pathways, a name that better reflects the public charity’s emphasis on expanding patient and physician access to investigational drugs and promoting inclusion in clinical research. “Although our name has changed, our vision remains the [...]

May 22, 2018|Categories: News|

Republicans Get Ready to Vote on “Right-to-Try” Bill Again

Published March 19, 2018 by The American Journal of Managed Care The right-to-try bill, which suffered a surprise 259-140 defeat in the House of Representatives last week, is scheduled for another vote this week, perhaps as early as Wednesday. On Monday, the House Committee on Rules was scheduled to meet late in the day to change the procedure so that it could be passed with just a simple majority, rather than a two-thirds majority, and this time approval seems [...]

March 19, 2018|Categories: News|

Weighing the Merits of Right-to-Try Laws and FDA’s Expanded Access Program

Published February 27, 2018 by The American Journal of Managed Care Just a month before attendees gathered in Philadelphia, Pennsylvania, for the annual meeting of Patient-Centered Oncology Care®, legislators in the state’s capital of Harrisburg made it the 38th to pass a right-to-try law. That was 6 states in 2017 alone.1 Championed by conservative groups like the Goldwater Institute as well as Vice President Mike Pence,2 the laws sound good on their face: they can connect terminally ill patients with [...]

February 27, 2018|Categories: News|

Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

Presenters include Richard Klein, formerly of FDA, and Marjorie Speers of WCGF ATLANTA, Ga., Jan. 9, 2018—WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients. The webinars—“Intermediate-Size Patient Populations INDs: What Are They, When Should They Be Used, and Who May Apply for Them?”—feature Richard Klein, former director of the Food and Drug Administration Patient Liaison Program Office, and Marjorie [...]

January 9, 2018|Categories: News|

Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

Presenters include Richard Klein, formerly of FDA, and Marjorie Speers of WCGF ATLANTA, Ga.,  Jan. 9, 2018—WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients. The webinars—“Intermediate-Size Patient Populations INDs: What Are They, When Should They Be Used, and Who May Apply for Them?”—feature Richard Klein, former director of the Food and Drug Administration Patient Liaison Program Office, and Marjorie [...]

January 9, 2018|Categories: News|

Right to Try Bills Push the Needle on Risk’ –  panel of experts, including WCGF Executive Director Marjorie A. Speers, discuss risks associated with Right-to-Try legislation

Published December 24, 2017 by OncLive "Congressional “right-to-try” legislation could make investigational drugs available to desperately ill patients sooner in the trials process, but there are substantial risks, said a panel of experts at the Patient-Centered Oncology Conference, held November 16-17 in Philadelphia, Pennsylvania. Earlier in the clinical trials process, less is known about the drugs, which may be highly toxic and may have no efficacy. Furthermore, the House of Representatives’ version of the bill would allow companies to [...]

December 24, 2017|Categories: News|
Load More Posts